Phytochemical screening and evaluation of antibacterial, antitubercular activi- ties of Peganum harmala linn., seeds
暂无分享,去创建一个
[1] M. Prévost,et al. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). , 2014, Journal of ethnopharmacology.
[2] Y. Kumar,et al. Antimicrobial and antihyperglycemic activities of Musa paradisiaca flowers , 2012 .
[3] I. Chen,et al. Antitubercular chromones and flavonoids from Pisonia aculeata. , 2011, Journal of natural products.
[4] V. Arán,et al. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] M. M. Oloumi,et al. Study on the effect of Peganum harmala extract on experimental skin wound healing in rat: pathological and biomechanical findings , 2010, Comparative Clinical Pathology.
[6] W. S. Qazan. The effect of low levels of dietary Peganum harmala L. and Ballota undulata or their mixture on chicks. , 2009 .
[7] Hiroshi Morita,et al. Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities , 2008, Journal of Natural Medicines.
[8] S. Satish,et al. Antimicrobial Activity of Some Important Medicinal Plant Against Plant and Human Pathogens , 2008 .
[9] K. Al-shamma,et al. Acute Toxicological Studies on the Extract of Iraqi Peganum Harmala in Rats , 2008 .
[10] Yves L Janin,et al. Antituberculosis drugs: ten years of research. , 2007, Bioorganic & medicinal chemistry.
[11] Guangling Li,et al. Effect of total alkaloid ofPeganum harmala L. in the treatment of experimental haemosporidian infections in cattle , 2007, Tropical Animal Health and Production.
[12] H. Berrougui,et al. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. , 2006, Pharmacological research.
[13] S. Gibbons,et al. Antimicrobial, resistance‐modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. and Microglossa pyrifolia Lam. , 2006, Phytotherapy research : PTR.
[14] K. D. Tripathi,et al. Essentials of Medical Pharmacology , 2004 .
[15] G. di Perri,et al. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? , 2004, The Journal of antimicrobial chemotherapy.
[16] A. Okunade,et al. Natural antimycobacterial metabolites: current status. , 2004, Phytochemistry.
[17] C. Di Giorgio,et al. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. , 2004, Experimental parasitology.
[18] M. Abdollahi,et al. Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[19] G. Asghari,et al. STEREOSPECIFIC BIOTRANSFORMATION OF (±) PHENYLETHYL PROPIONATE BY CELL CULTURES OF PEGANUM HARMALA L. , 2002 .
[20] M. Mahmoudian,et al. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[21] B. Lyoussi,et al. Antitumour principles from Peganum harmala seeds. , 1999, Therapie.
[22] Robert H. Gilman,et al. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.
[23] Z. Ling,et al. Effect of total alkaloid of Peganum harmala L. in the treatment of experimental haemosporidian infections in cattle. , 1997 .
[24] R. Chemli,et al. Peganum harmala L: a poisonous plant of North Africa. , 1991, Veterinary and human toxicology.
[25] G. Cordell,et al. Can ethnopharmacology contribute to the development of new anticancer drugs? , 1991, Journal of ethnopharmacology.
[26] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.